paracetamol dr. max 500 mg tablety
dr. max pharma ltd. - paracetamol - 07 - analgetica, antipyretica
etrixenal 250 mg tablety
proenzi, s.r.o., Česká republika - naproxén - 29 - antirheumatica, antiphlogistica, antiuratica
parapyrex
dr. max pharma s.r.o., Česká republika - paracetamol - 07 - analgetica, antipyretica
adnebol 500 mg
adamed pharma s.a., poľsko - naproxén - 29 - antirheumatica, antiphlogistica, antiuratica
coldrex grip plus kašeľ s príchuťou citrónu a mentolu
omega pharma a.s., Česká republika - paracetamol, kombinácie s výnimkou psycholeptík - 07 - analgetica, antipyretica
flurbiprofen sejmet 8,75 mg orálna roztoková aerodisperzia
sejmet pharmaceuticals sl, Španielsko - flurbiprofén - 69 - otorhinolaryngologica
parastad mäkké kapsuly
stada arzneimittel ag, nemecko - paracetamol - 07 - analgetica, antipyretica
coxtral
zentiva k.s., Česká republika - nimesulid - 29 - antirheumatica, antiphlogistica, antiuratica
paracetamol pxgpharma 500 mg filmom obalené tablety
pxg pharma gmbh, nemecko - paracetamol - 07 - analgetica, antipyretica
clopidogrel acino
acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotické činidlá - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.